Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Basal Health vs PepHaūs

Basal Health
Graded #494

Lower grade

vs+35
PepHaūs
Graded #32

Higher grade

The verdict

PepHaūs takes it — 82.7/100 to 47.7/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePepHaūs +37
45
82
Dose & formulationPepHaūs +40
40
80
Clinical oversightPepHaūs +36
48
84
Labs & monitoringPepHaūs +32
50
82
FulfillmentPepHaūs +28
58
86
Contract termsPepHaūs +30
55
85
Basal Health · left barPepHaūs · right bar

The numbers

MetricBasal HealthPepHaūs
WeighScore47.7/10082.7/100
GradeCB−
Scorecard rank#494#32
SemaglutideNot disclosed$152/mo
TirzepatideNot disclosed$246/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Basal Health

Graded #494 · C

Strengths

  • Stated nationwide coverage (50 states + DC)
  • Metabolic-framework positioning rather than single-product
  • Clinician-supervised dosing rather than a fixed protocol
  • Adaptive monitoring approach

Where it loses points

  • No pricing shown publicly — you must complete intake to see cost
  • Compounding pharmacy partner not named
  • GLP-1 molecules not specified (semaglutide vs tirzepatide vs oral)
  • No LegitScript badge visible on the homepage
  • No FDA compounded-medication disclaimer on the pages reviewed
PepHaūs

Graded #32 · B−

Strengths

  • LegitScript-verified, all 50 states
  • Both molecules
  • Transparent listed pricing

Where it loses points

  • Upper-mid pricing ($152/$246)
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard